Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World

Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World

Neuroendocrine tumors overexpress somatostatin receptors, which serve as important and unique therapeutic targets for well-differentiated advanced disease. This overexpression is a well-established finding in gastroenteropancreatic neuroendocrine tumors which has guided new medical therapies in the...

Full description

Bibliographic Details
Main Authors:	Mayank Patel, Isabel Tena, Abhishek Jha, David Taieb, Karel Pacak
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Endocrinology
Subjects:	pheochromocytoma paraganglioma somatostatin receptors somatostatin analog peptide receptor radionuclide therapy 68Ga-DOTATATE
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.625312/full

Similar Items

Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma
by: Abhishek Jha, et al.
Published: (2019-02-01)

Two Birds with One Stone: Skull Base Meningioma and Jugulotympanic Paragangliomas with Somatostatin Receptor Positron Emission Tomography
by: Giorgio Treglia, et al.
Published: (2021-09-01)

Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging
by: Rami Alrezk, et al.
Published: (2018-11-01)

Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
by: Yuheng Hu, et al.
Published: (2021-05-01)

Supportive Management of Patients with Advanced Pheochromocytomas and Paragangliomas Receiving PRRT
by: Erica S. Tsang, et al.
Published: (2021-07-01)

A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
by: Rosalba Mansi, et al.
Published: (2020-08-01)

Case report 68Ga-DOTATATE of optic nerve sheath meningioma
by: Adeleh Yarmohammadi, et al.
Published: (2021-06-01)

Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
by: Valentina Rossi, et al.
Published: (2019-02-01)

Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma
by: Sriram Gubbi, et al.
Published: (2021-01-01)

Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
by: Martin H. Cherk, et al.
Published: (2018-01-01)

Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
by: Romain Eychenne, et al.
Published: (2020-09-01)

Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of177Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors
by: Rahul V Parghane, et al.
Published: (2019-01-01)

Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report
by: Michele Guida, et al.
Published: (2020-07-01)

Expression of Somatostatin Receptor Subtypes (SSTR-1–SSTR-5) in Pediatric Hematological and Oncological Disorders
by: Kristof Harda, et al.
Published: (2020-12-01)

Metastatic clear cell renal cell carcinoma demonstrating intense uptake on 68Ga-DOTATATE positron emission tomography: Three case reports and a review of the literature
by: David P Nadebaum, et al.
Published: (2018-01-01)

Demonstration of focal physiologic in-vivo somatostatin receptor expression in the caput epididymis of the testes on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE post-therapy whole body scintigraphy
by: Ashwin Parihar, et al.
Published: (2020-07-01)

Metastatic urinary bladder paraganglioma on Ga-68 DOTATATE PET/CT
by: Andrew Ko, BSA, et al.
Published: (2021-09-01)

Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
by: Arman Romiani, et al.
Published: (2021-08-01)

68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
by: Tessel M. Boertien, et al.
Published: (2020-02-01)

68Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia
by: Manav I Bhalla, et al.
Published: (2020-01-01)

SOMATOSTATIN RECEPTORS AS POTENTIALTHERAPEUTIC TARGETS IN THE TREATMENT OF ADVANCED ADRENOCORTICAL CANCER. A CASE REPORT
by: A. A. Kolomeytseva, et al.
Published: (2018-05-01)

Treatment of Advanced Hepatocellular Carcinoma with Somatostatin Analogues: A Review of the Literature
by: Hendrik Reynaert, et al.
Published: (2019-09-01)

Somatostatin receptor 1,2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo; analysis of the intracellular pathways involved
by: M. Gatti, et al.
Published: (2011-01-01)

A Care Process Model to Deliver 177Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors
by: Pashtoon Murtaza Kasi, et al.
Published: (2019-01-01)

Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity
by: Ujendra Kumar, et al.
Published: (2020-04-01)

A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation
by: Agnieszka Kolasinska-Ćwikła, et al.
Published: (2019-06-01)

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with <sup>177</sup>Lu-DOTATATE
by: Achyut Ram Vyakaranam, et al.
Published: (2019-06-01)

Preoperative Management of Pheochromocytoma and Paraganglioma
by: Fang Fang, et al.
Published: (2020-09-01)

Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer
by: Camilo Jimenez
Published: (2018-05-01)

68Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients
by: Virginia Liberini, et al.
Published: (2021-01-01)

Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms
by: Maria Celeste Cantone, et al.
Published: (2021-02-01)

Somatostatin Receptor Subtype Expression in Patients with Acromegaly and Complicated Clinical Course
by: Robert Pichler, et al.
Published: (2021-06-01)

Adherence to somatostatin analog therapy for acromegaly
by: I. A. Ilovayskaya
Published: (2021-05-01)

A case of malignant insulinoma responsive to somatostatin analogs treatment
by: Mariasmeralda Caliri, et al.
Published: (2018-12-01)

Review of Pediatric Pheochromocytoma and Paraganglioma
by: Reshma Bholah, et al.
Published: (2017-07-01)

Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
by: Bilal Haider Shamsi, et al.
Published: (2021-03-01)

Unresectable Recurrent Multiple Meningioma: A Case Report with Radiological Response to Somatostatin Analogues
by: Ana Ortolá Buigues, et al.
Published: (2016-08-01)

Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms
by: Federico Gatto, et al.
Published: (2019-08-01)

Pulmonary large cell neuroendocrine carcinoma (LCNEC) with confirmed liver metastases negative on 18F-FDG and 68Ga-DOTATATE PET
by: Gaia Ninatti, et al.
Published: (2020-12-01)

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
by: Wei Wu, et al.
Published: (2020-09-01)